Hold Ionis Pharmaceuticals as the share price moved to find a $60 valuation

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is on a bullish streak that began three weeks ago. Last week, the brand reported success in research on a cholesterol drug that it is developing in partnershi...